U.S. Cell Culture Media Market Size, Share & COVID-19 Impact Analysis, By Type (Classical Media, Specialty Media, Serum Free Media, and Others), By Application (Drug Screening and Development, Research, and Others), By End-User (Biotechnology and Pharmaceutical Companies, Academic & Research Institutes, and Others), and Country Forecast, 2023-2030

The U.S. cell culture media market size was worth USD 990.0 million in 2022 and is projected to grow at a CAGR of 11.4% during the forecast period.            

Cell culture media is generally a liquid or gel that constitutes of several components that are required for the growth, propagation, maintenance, and storage of micro-organisms. These products play an important role in the manufacturing of biopharmaceutical drugs, along with other research-related activities. Thus, the increasing research and development in the biopharmaceutical sector for the introduction of new innovative therapies is expected to drive market growth in the country.

Furthermore, in recent years, the development of Adeno-Associated Virus (AAV) vectors using cell culture has gained significant traction in vaccine manufacturing. These vectors have several advantages such as a wide host-cell range and a relatively high transduction capacity, in turn increasing demand for these vectors. This has resulted in a growing usage of these products. Moreover, the increasing number of product approvals for biosimilars has created lucrative opportunities for manufacturers to launch new products in the market.

On the other hand, the COVID-19 pandemic positively impacted the market due to the increased usage of these products in vaccine manufacturing. Operating companies registered a notable increase in their revenues due to exponentially increased demand for these products.

LATEST TRENDS

Growing Trend Toward the Use of Advanced Innovative Cell Culture Technologies 

In recent years, the research community has been actively focusing on the development and introduction of new technologies that increase the efficiency of cell culture media. For instance, the addition of nanofibre in the development of cell culture media is one of the advancements in technology. This addition enhances the real-time quantification of cell mobility, resulting in better outcomes.

Similarly, the addition of recombinant mammalian albumin plays an important role in the bio-manufacturing of recombinant proteins and therapeutic monoclonal antibodies.

The adoption of advanced technologies in recent years is one of the significant trends in the market.

DRIVING FACTORS

Growing Demand for Vaccines to Boost the Market Growth

Cell culture media have wide applications in the development of biopharmaceutical products, including cell culture-based vaccines. The rising incidence of infectious diseases coupled with outbreaks of various pandemics, has resulted in high demand for vaccines for the management of these diseases. To cater to this high market demand, the manufacturers have shifted their focus on expanding their cell culture media production capabilities in the country.

• For instance, in July 2023, Merck KGaA announced an investment of around USD 25 million (EUR 23 million) to expand cell culture media production in Kansas, the U.S.

The above-mentioned factors along with extensive research in therapy development, has bolstered market growth.

Download Free sample to learn more about this report.

According to an article published by Nature Biology in December 2022, 29% of all genuinely novel drug approvals in the U.S. were biopharmaceuticals.

RESTRAINING FACTORS

High Cost of Cell Biology Research Products to Impede Growth Prospects 

One of the key factors restraining the U.S. cell culture media market growth includes the high cost of cell biology research products in the country. Development of new therapies such as cell and gene therapies, requires extensive research and the use of high-quality products for precise and accurate results. Owing to budget constraints, various research laboratories and small-scale companies look for alternatives to these expensive products. The above-mentioned factors are expected to hinder the market growth to a certain extent.

SEGMENTATION

By Type Analysis

On the basis of type, the market is segmented into classical media, specialty media, serum-free media, and others.

The classical media segment accounted for the largest U.S. cell culture media market share in 2022. The increasing research and development activities by biotechnology & biopharmaceutical companies for new product development has driven the demand for classical media products in the country. In addition to this, the focus of key industry players on new product launches is also fueling segment growth.

• For instance, in April 2022, Captivate Bio launched new classical media to expand its product portfolio. This new product is expected to support research activities.

The serum-free media segment is anticipated to witness the fastest growth over the forecast period. The advantages offered by these products, such as increased productivity, reduced risk of contamination, more consistent performance, and others result in increasing adoption of the product. This is expected to drive the segment growth.

By Application Analysis

Based on application, the market is categorized into drug screening & development, research, and others.

The drug screening & development segment captured the dominating position in the market in 2022. Increasing demand for new, innovative, and effective therapeutic treatments for various indications is fueling the segment growth. Additionally, the rising demand for vaccines, as well as the increasing adoption of cell-based arrays for drug discovery & development, further fueling the segment growth.

On the other hand, the research segment is anticipated to witness considerable growth over the forecast period. The high spending on research & development by drug manufacturers is responsible for the growth of this segment.

By End-User Analysis

Based on end-user, the market is segmented into biotechnology & pharmaceutical industries, academic & research laboratories, and others.

In 2022, the biotechnology & pharmaceutical industries segment held the leading share in the U.S. cell culture media market. Factors contributing to the dominance of the segment include a rising focus on the research and development of new drug products and an increasing number of regulatory approvals for biologics such as vaccines and others.

On the other hand, the academic & research laboratories segment is projected to grow considerably during the forecast period. The increasing involvement of the research community in various studies in the country is expected to boost segment growth.

KEY INDUSTRY PLAYERS

The competitive marketspace for the industry reflects a consolidated structure. Major players such as Thermo Fisher Scientific, Danaher, and Merck KGaA dominated the U.S. market with a significant combined share. A strong focus on the expansion of production capabilities, continuous efforts for the introduction of new products, and a wide distribution network are some of the factors contributing to their market dominance.

• For instance, in March 2021, Thermo Fisher Scientific introduced a new Gibco Human Plasma-like Medium (HPLM) in the market. This medium was aimed to provide a realistic view of cell growth within the human body.

Some other prominent players operating in the market include FUJIFILM Irvine Scientific, BD, Sartorius AG, and others. These companies are focusing on expanding their product portfolio to enhance their market presence.

LIST OF KEY COMPANIES PROFILED:

• FUJIFILM Irvine Scientific (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Becton Dickinson and Company (BD) (U.S.)
• Merck KgaA (Germany)
• Sartorius AG (Germany)
• Corning Incorporated (U.S.)
• Lonza (Switzerland)
• Danaher (U.S.)

KEY INDUSTRY DEVELOPMENTS: 

• July 2023 – MilliporeSigma invested USD 25 million for the expansion of cell culture media production in Kansas, U.S.
• November 2022 – FUJIFILM Corporation invested USD 188 million for the establishment of a cell culture media manufacturing facility in the U.S.
• August 2022 – Thermo Fisher Scientific invested USD 76 million for the expansion of production capacity at its New York plant.

REPORT COVERAGE

An Infographic Representation of U.S. Cell Culture Media Market

View Full Infographic

To get information on various segments, share your queries with us

The U.S. cell culture media market report provides a detailed analysis of the market. It focuses on key market segments such as type, application, and end-user. Additionally, it includes detailed insights on market dynamics, new product launches, key industry developments such as mergers, partnerships, and acquisitions, and the impact of COVID-19 on the market. The report also provides the competitive landscape discussing the key companies in the U.S. market.

Report Scope & Segmentation